Get to “How It’s Going” with XDEMVY®, the first and only FDA-approved treatment made specifically to treat Demodex blepharitis. Indications and Usage: XDEMVY (lotilaner ophthalmic solution) 0.25% is indicated for the treatment of Demodex blepharitis. Important Safety Information: Most common side effects: The most common side effect in clinical trials was stinging and burning in 10% of patients. Other side effects in less than 2% of patients were chalazion/hordeolum and punctate keratitis. Pleas

Ophthalmologist Dr. Christopher Starr and our sponsor Tarsus Pharmaceuticals, Inc. share how to spot the signs of Demodex blepharitis, a common eye disease that impacts nearly 25 million eye care patients. Learn more: eyelidcheck.com | The View